S&P rates Viant loan B-

S&P said it assigned a B- with a 3 recovery rating to Viant Medical Holdings Inc.’s new $120 million secured loan. In addition, the agency affirmed the B- issue rating on the existing first-lien term loan and CCC issue rating the outstanding second-lien term loan. The recovery ratings remain 3 and 6, respectively.

Viant Medical’s recently completed leverage-neutral refinancing transaction significantly improved its liquidity position, giving the company more time and headroom to complete its revenue cycle management system transition and improve profitability and cash generation, the agency said.

The outlook is stable.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.